TGFB1 and renal fibrosis: Our studies have demonstrated that blockade of KCa3.1 alleviated renal fibrosis and inflammation in diabetic mice through inhibition of the TGF-β1 signaling pathway and fibroblast activation (Huang et al., 2013, 2014b).